Orthofix Medical Appoints Michael Finegan as Chair of the Board

Share This Post

Key Highlights

  • Michael Finegan appointed as Chair of the Board of Orthofix Medical Inc.
  • Former Chair Cathy Burzik recognized for her leadership.
  • Finegan brings experience from Acera Surgical and Orthofix.
  • Orthofix positioned for profitable growth and shareholder value.
  • Company’s global footprint spans multiple countries.

Source: Business Wire

Notable Quotes

  • “I have a long history with Orthofix, and it is an honor to be selected to lead the Board of Directors. The company has undergone a transformation and I believe is well-positioned to deliver profitable growth and significant, sustainable shareholder value as we fulfill our mission of providing life-changing solutions for patients.” — Michael Finegan, CEO at Acera Surgical
  • “We are grateful to former Chair Cathy Burzik for her outstanding leadership, and I would like to thank her for all she has done for Orthofix and wish her the best as she continues to make a difference in the healthcare industry. His years of experience in the industry and specifically with Orthofix, will provide the Board with an important dimension and a tremendously valuable perspective to take us into our next chapter of growth.” — Massimo Calafiore, President and CEO at Orthofix

SoHC's Take

The appointment of Michael Finegan as the new Chair of Orthofix Medical Inc. marks a strategic move for the company. Finegan’s extensive background in the spine and orthopedics industry, coupled with his previous experience at Orthofix and Acera Surgical, positions him as an ideal leader to drive the company’s next phase of growth. His leadership is expected to enhance Orthofix’s ability to innovate and deliver value to shareholders, aligning with the company’s mission to provide life-changing solutions for patients worldwide. The acknowledgment of Cathy Burzik’s contributions highlights a seamless leadership transition that ensures stability and continued progress for Orthofix.

More To Explore

Total
0
Share